UBV
AUTL icon

United Bank (Virginia)’s Autolus Therapeutics AUTL Stock Holding History

United Bank (Virginia)’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,850
Closed -$25.5K – 139
2024
Q4 		$25.5K Hold
10,850
– – ﹤0.01% 131
2024
Q3 		$39.4K Sell
10,850
-650
-6% -$2.59K ﹤0.01% 138
2024
Q2 		$40K Hold
11,500
– – 0.01% 137
2024
Q1 		$73.4K Hold
11,500
– – 0.01% 142
2023
Q4 		$74.1K Hold
11,500
– – 0.01% 140
2023
Q3 		$26.8K Hold
11,500
– – ﹤0.01% 143
2023
Q2 		$27.4K Buy
11,500
+1,200
+12% +$2.85K ﹤0.01% 152
2023
Q1 		$19K Hold
10,300
– – ﹤0.01% 156
2022
Q4 		$19.6K Buy
+10,300
New +$26K ﹤0.01% 154

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

United Bank (Virginia)'s AUTL Position: Q1 2025 in Review

United Bank (Virginia) sold out of Autolus Therapeutics (AUTL) in Q1 2025, closing a stake of 10,850 shares — an estimated $25.5K sold.

United Bank (Virginia) first reported a position in AUTL in Q4 2022 and held it in 9 quarters. The position peaked at $74.1K in Q4 2023. 95 funds tracked by Wall St. Rank hold AUTL as of Q1 2025.

  • United Bank (Virginia) reported no remaining Autolus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • United Bank (Virginia) sold 10,850 Autolus Therapeutics shares in Q1 2025, an estimated $25.5K.
  • United Bank (Virginia) first reported a position in Autolus Therapeutics in Q4 2022 and held it in 9 quarters.
  • United Bank (Virginia)'s Autolus Therapeutics position peaked at $74.1K in Q4 2023.
  • 95 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2025.

Based on United Bank (Virginia)'s 13F filing for Q1 2025, filed 14 May 2025.